The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds
investors of the upcoming deadline to move for appointment as lead
plaintiff in securities
class litigation brought on behalf of investors who purchased or
otherwise acquired the securities of Nobilis Health Corp. (“Nobilis”
or the “Company”) (NYSE: HLTH) between April 2, 2015 and October 8,
2015, inclusive (the “Class Period”).
If you purchased or otherwise acquired the securities of Nobilis during
the Class Period, you may move the Court for appointment as lead
plaintiff by no later than December 21, 2015. A lead plaintiff is a
representative party who acts on behalf of other class members in
directing the litigation. Your share of any recovery in the action will
not be affected by your decision of whether to seek appointment as lead
plaintiff. You may retain Lieff Cabraser, or other attorneys, as your
counsel in the action.
Nobilis
investors who wish to learn more about the action and how to seek
appointment as lead plaintiff should click here or contact Sharon M.
Lee of Lieff Cabraser toll-free at 1-800-541-7358.
The complaint alleges that throughout the Class Period, defendants made
materially false and misleading statements and failed to disclose that:
(i) Nobilis’s AccuraScope procedure, a purportedly minimally invasive
spine surgery, lacked recognition from any university, medical body, or
insurance company; (ii) the Company had overstated its 2014 revenues by
as much as $36 million; and (iii) consequently, the Company had
misrepresented its 2014 revenue growth rate as 161%, when it was
actually only 44%.
On October 9, 2015, Seeking Alpha published an article describing
the AccuraScope procedure’s “questionable insurability, unsubstantiated
success rates, [and] lack of recognition from” universities, medical
bodies, and insurance companies. The article additionally noted
significant accounting red flags at Nobilis and reported that Nobilis
had overstated its 2014 revenues by as much as $36 million. On this
news, the price of Nobilis common stock fell $1.42 per share, or 27%
from its closing price of $5.24 on October 8, 2015 to close at $3.82 per
share on October 9, 2015, on extremely heavy trading volume.
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP is a nationally recognized law
firm committed to advancing investor rights and promoting corporate
responsibility.
For twelve years, the National Law Journal has selected Lieff
Cabraser as one of the top plaintiffs’ law firms in the nation. Best
Lawyers and U.S. News have also named Lieff Cabraser as a
“Law Firm of the Year” each year the publications have given this award
to law firms, including in 2015.
For more information about Lieff Cabraser and the firm’s representation
of investors, please visit http://www.lieffcabraser.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151104006906/en/
Copyright Business Wire 2015